Abstract:
PURPOSE: A composition containing Phellodendri Cortex extract is provided to suppress acne pigmentation in a cosmetic, food, or medical field. CONSTITUTION: A composition for suppressing pigmentation by acne contains 0.5-20 weight% of Phellodendri Cortex extract as an active ingredient. An external use skin composition contains the composition for suppressing pigmentation. The composition is a cosmetic formulation. A composition for aftercare of acne contains Phellodendri Cortex extract as an active ingredient. A food additive or health food composition contains the composition for suppressing pigmentation or aftercare.
Abstract:
PURPOSE: A composition containing Glycyrrhiza Uralensis Fischer extract is provided to suppress pigmentation and/or scar by acne and to be used in cosmetic or medical field. CONSTITUTION: A composition for suppressing pigmentation or scar by acne contains Glycyrrhiza Uralensis Fischer extract as an active ingredient. The Glycyrrhiza Uralensis Fischer extract suppresses gelatinase. An external use composition contains the composition for suppressing pigmentation or scar. The composition is a cosmetic formulation. An aftercare composition for acne sequel contains Glycyrrhiza Uralensis Fischer extract as an active ingredient.
Abstract:
PURPOSE: A composition containing Saururus chinensis extract is provided to suppress pigmentation and/or scar. CONSTITUTION: A composition for preventing pigmentation or scar by acne contains 0.5-2.0 weight% of Saururus chinensis extract. An external use skin composition contains the composition for preventing pigmentation or scar by acne. The composition is a cosmetic formulation. A food additive or health food composition contains the composition for preventing pigmentation or scar or after care composition.
Abstract:
A composition for external application for treating and preventing the pruritus or irritant skin disease is provided to have excellent fluxes and stability by containing the thiourea derivative and to be useful in pruritus or irritant skin disease. A composition for external application of O/w-shaped emulsion form comprises (1) drug expressed as a compound of a chemical formula 1, (2) a component selected from a group consisting of squalene, dimethicone, propylene glycol, butylene glycol and mineral oil, (3) a component selected from a group consisting of polyethylene glycol 400, polyoxyethylene alkyl ether, cetyl alcohol and solbitan stearate, (4) water and (5) a component selected from a group consisting of ethanol, twin 60, carbomer 940, EDTA.2Na and triethanolammine.
Abstract:
본 발명은 자기회합성을 갖는 양친성 고분자를 사용하여 난용성 육모 물질을 포집시켜 제조한 나노입자 및 이를 함유하는 두피 넓게는 피부 외용제 조성물에 관한 것이다. 보다 구체적으로, 본 발명은 소수성 폴리에스테르 고분자(A)와 친수성 고분자(B)를 결합시켜 제조한 블록공중합체(AB) 형태의 자기회합성(self-assembling)을 갖는 양친성 고분자를 사용하여 수용액상에서 난용성의 발모 활성 성분인 피나스테라이드를 포집시켜 제조한 나노입자 및 이를 유효성분으로 함유하는 두피 및 피부 외용제 조성물에 관한 것이다. 본 발명에 의한 나노입자는 난용성 또는 불용성의 생리활성 유효성분인 피나스테라이드를 포집시켜 나노 수준의 크기로 캡슐화하여 수분산 상태의 입자로 제조한 것으로, 활성 성분의 모낭 전달 효과 및 흡수율이 뛰어나고, 다양한 외용제 제형에 용이하게 적용할 수 있는 뛰어난 효과가 있다.